Meanwhile, World Courier remains up for bid, possibly to be acquired by FedEx
Marken (London, US HQ in Uniondale, NY), a leading provider of clinical trial logistics, has received a “expanded” business license to allow the storage and distribution of clinical trial materials (CTMs) in China, where it already has a courier business. Also within recent weeks, it has organized a competency center around cold chain services (for both clinical and commercial logistics), hired a QA manager for its Berlin office, and promoted the availability of two IT systems (Solo, a tracking and planning system, and Maestro, a client web portal). And it has ambitious growth plans: "We have an aggressive plan to build six more purpose-built pharmaceutical service depots this year," said Frank Wright, president, clinical trials distribution, in a press release. "With the completion of Argentina and the start of Beijing, we are off to a strong start in 2012. We have engaged a global engineering and construction firm to assist us and ensure that the standards of construction are up to the highest standards in the industry."
Meanwhile, there continue to be press reports of an on-again, off-again negotiation for selling World Courier, another major CTMs courier service. Earlier press reports had said that UPS had looked at, but then passed on, acquiring the New Hyde Park, NY company; now FedEx is rumored to be at the bargaining table.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.